Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

Hsp70 facilitates trans-membrane transport of bacterial ADP-ribosylating toxins into the cytosol of mammalian cells.

Ernst K, Schmid J, Beck M, Hägele M, Hohwieler M, Hauff P, Ückert AK, Anastasia A, Fauler M, Jank T, Aktories K, Popoff MR, Schiene-Fischer C, Kleger A, Müller M, Frick M, Barth H.

Sci Rep. 2017 Jun 2;7(1):2724. doi: 10.1038/s41598-017-02882-y.

2.

Comparable rest-related promotion of spatial memory consolidation in younger and older adults.

Craig M, Wolbers T, Harris MA, Hauff P, Della Sala S, Dewar M.

Neurobiol Aging. 2016 Dec;48:143-152. doi: 10.1016/j.neurobiolaging.2016.08.007. Epub 2016 Aug 31.

3.

Targeted ED-B fibronectin SPECT in vivo imaging in experimental atherosclerosis.

Dietrich T, Berndorff D, Heinrich T, Hucko T, Stepina E, Hauff P, Dinkelborg LM, Atrott K, Giovannoni L, Neri D, Fleck E, Graf K, Menssen HD.

Q J Nucl Med Mol Imaging. 2015 Jun;59(2):228-37.

PMID:
25864530
4.

Early to Phase II drugs currently under investigation for the treatment of liver fibrosis.

Hauff P, Gottwald U, Ocker M.

Expert Opin Investig Drugs. 2015 Mar;24(3):309-27. doi: 10.1517/13543784.2015.997874. Epub 2014 Dec 30. Review.

PMID:
25547844
5.

Anetumab ravtansine: a novel mesothelin-targeting antibody-drug conjugate cures tumors with heterogeneous target expression favored by bystander effect.

Golfier S, Kopitz C, Kahnert A, Heisler I, Schatz CA, Stelte-Ludwig B, Mayer-Bartschmid A, Unterschemmann K, Bruder S, Linden L, Harrenga A, Hauff P, Scholle FD, Müller-Tiemann B, Kreft B, Ziegelbauer K.

Mol Cancer Ther. 2014 Jun;13(6):1537-48. doi: 10.1158/1535-7163.MCT-13-0926. Epub 2014 Apr 8.

6.

The proline TP53 variant stimulates likely lymphangiogenesis in an orthotopic mouse model of pancreatic cancer.

Otto N, Schulz P, Scholz A, Hauff P, Schlegelberger B, Detjen KM, Wiedenmann B.

Br J Cancer. 2012 Jan 17;106(2):348-57. doi: 10.1038/bjc.2011.521. Epub 2011 Dec 6.

7.

Angiopoietin-2 drives lymphatic metastasis of pancreatic cancer.

Schulz P, Fischer C, Detjen KM, Rieke S, Hilfenhaus G, von Marschall Z, Böhmig M, Koch I, Kehrberger J, Hauff P, Thierauch KH, Alves F, Wiedenmann B, Scholz A.

FASEB J. 2011 Oct;25(10):3325-35. doi: 10.1096/fj.11-182287. Epub 2011 Jun 17.

PMID:
21685330
8.

Temporal pattern of ICAM-I mediated regulatory T cell recruitment to sites of inflammation in adoptive transfer model of multiple sclerosis.

Doerck S, Göbel K, Weise G, Schneider-Hohendorf T, Reinhardt M, Hauff P, Schwab N, Linker R, Mäurer M, Meuth SG, Wiendl H.

PLoS One. 2010 Nov 15;5(11):e15478. doi: 10.1371/journal.pone.0015478.

9.

D-18F-fluoromethyl tyrosine imaging of bone metastases in a mouse model.

Zitzmann-Kolbe S, Strube A, Frisk AL, Käkönen SM, Tsukada H, Hauff P, Berndorff D, Graham K.

J Nucl Med. 2010 Oct;51(10):1632-6. doi: 10.2967/jnumed.110.078899. Epub 2010 Sep 16.

10.

Pulsatile shear and Gja5 modulate arterial identity and remodeling events during flow-driven arteriogenesis.

Buschmann I, Pries A, Styp-Rekowska B, Hillmeister P, Loufrani L, Henrion D, Shi Y, Duelsner A, Hoefer I, Gatzke N, Wang H, Lehmann K, Ulm L, Ritter Z, Hauff P, Hlushchuk R, Djonov V, van Veen T, le Noble F.

Development. 2010 Jul;137(13):2187-96. doi: 10.1242/dev.045351.

11.

Characterization of a new renal cell carcinoma bone metastasis mouse model.

Strube A, Stepina E, Mumberg D, Scholz A, Hauff P, Käkönen SM.

Clin Exp Metastasis. 2010 May;27(5):319-30. doi: 10.1007/s10585-010-9329-9. Epub 2010 May 5.

PMID:
20443133
12.

Angiopoietin-2 promotes disease progression of neuroendocrine tumors.

Detjen KM, Rieke S, Deters A, Schulz P, Rexin A, Vollmer S, Hauff P, Wiedenmann B, Pavel M, Scholz A.

Clin Cancer Res. 2010 Jan 15;16(2):420-9. doi: 10.1158/1078-0432.CCR-09-1924. Epub 2010 Jan 12.

13.

High-resolution ultrasound imaging: a novel technique for the noninvasive in vivo analysis of endometriotic lesion and cyst formation in small animal models.

Laschke MW, Körbel C, Rudzitis-Auth J, Gashaw I, Reinhardt M, Hauff P, Zollner TM, Menger MD.

Am J Pathol. 2010 Feb;176(2):585-93. doi: 10.2353/ajpath.2010.090617. Epub 2009 Dec 30.

14.

Comparison of conventional time-intensity curves vs. maximum intensity over time for post-processing of dynamic contrast-enhanced ultrasound.

Palmowski M, Lederle W, Gaetjens J, Socher M, Hauff P, Bzyl J, Semmler W, Günther RW, Kiessling F.

Eur J Radiol. 2010 Jul;75(1):e149-53. doi: 10.1016/j.ejrad.2009.10.030. Epub 2009 Nov 27.

PMID:
19945241
15.

Luminescent imaging technology as an opportunity to reduce and refine animal experiments: Light at the end of the tunnel?

Hagelschuer I, Hauff P, Strube A, Käkönen SM, von Degenfeld G.

ALTEX. 2009;26(3):177-85.

16.

Molecular ultrasound imaging of early vascular response in prostate tumors irradiated with carbon ions.

Palmowski M, Peschke P, Huppert J, Hauff P, Reinhardt M, Maurer M, Karger CP, Scholz M, Semmler W, Huber PE, Kiessling FM.

Neoplasia. 2009 Sep;11(9):856-63.

17.

[Molecular imaging in oncology using targeted ultrasound contrast agents].

Palmowski M, Palmowski M, Hauff P, Kiessling F.

Praxis (Bern 1994). 2009 May 27;98(11):597-602. doi: 10.1024/1661-8157.98.11.597. Review. German.

PMID:
19472145
18.

Sagopilone inhibits breast cancer bone metastasis and bone destruction due to simultaneous inhibition of both tumor growth and bone resorption.

Strube A, Hoffmann J, Stepina E, Hauff P, Klar U, Käkönen SM.

Clin Cancer Res. 2009 Jun 1;15(11):3751-9. doi: 10.1158/1078-0432.CCR-08-3123. Epub 2009 May 26.

19.

Development of pH-responsive core-shell nanocarriers for delivery of therapeutic and diagnostic agents.

Xu S, Luo Y, Graeser R, Warnecke A, Kratz F, Hauff P, Licha K, Haag R.

Bioorg Med Chem Lett. 2009 Feb 1;19(3):1030-4. doi: 10.1016/j.bmcl.2008.01.043. Epub 2008 Jan 18.

PMID:
19097889
20.

Repeated anaesthesia with isoflurane and xylazine/levomethadone/fenpipramide premedication in female Beagle dogs: influence on general health and wellbeing.

Bert B, Hartje I, Voigt JP, Arndt G, Ulbrich HF, Fink H, Hauff P.

Lab Anim. 2008 Oct;42(4):473-82. doi: 10.1258/la.2007.06023e. Epub 2008 Sep 9.

PMID:
18782826
21.

Vessel fractions in tumor xenografts depicted by flow- or contrast-sensitive three-dimensional high-frequency Doppler ultrasound respond differently to antiangiogenic treatment.

Palmowski M, Huppert J, Hauff P, Reinhardt M, Schreiner K, Socher MA, Hallscheidt P, Kauffmann GW, Semmler W, Kiessling F.

Cancer Res. 2008 Sep 1;68(17):7042-9. doi: 10.1158/0008-5472.CAN-08-0285.

22.

Monitoring therapeutical intervention with ezetimibe using targeted near-infrared fluorescence imaging in experimental atherosclerosis.

Graf K, Dietrich T, Tachezy M, Scholle FD, Licha K, Stawowy P, Grafe M, Hauff P, Fleck E.

Mol Imaging. 2008 Mar-Apr;7(2):68-76.

PMID:
18706289
23.

Dendritic multishell architectures for drug and dye transport.

Quadir MA, Radowski MR, Kratz F, Licha K, Hauff P, Haag R.

J Control Release. 2008 Dec 18;132(3):289-94. doi: 10.1016/j.jconrel.2008.06.016. Epub 2008 Jun 23.

PMID:
18639596
24.

Ultrasound contrast agents for molecular imaging.

Hauff P, Reinhardt M, Foster S.

Handb Exp Pharmacol. 2008;(185 Pt 1):223-45. doi: 10.1007/978-3-540-72718-7_11. Review.

PMID:
18626806
25.

Ultrasound basics.

Hauff P, Reinhardt M, Foster S.

Handb Exp Pharmacol. 2008;(185 Pt 1):91-107. doi: 10.1007/978-3-540-72718-7_5. Review.

PMID:
18626800
26.

Inducible re-expression of p16 in an orthotopic mouse model of pancreatic cancer inhibits lymphangiogenesis and lymphatic metastasis.

Schulz P, Scholz A, Rexin A, Hauff P, Schirner M, Wiedenmann B, Detjen K.

Br J Cancer. 2008 Jul 8;99(1):110-7. doi: 10.1038/sj.bjc.6604457. Epub 2008 Jun 24.

27.

Differentiation of angiogenic burden in human cancer xenografts using a perfusion-type optical contrast agent (SIDAG).

Wall A, Persigehl T, Hauff P, Licha K, Schirner M, Müller S, von Wallbrunn A, Matuszewski L, Heindel W, Bremer C.

Breast Cancer Res. 2008;10(2):R23. doi: 10.1186/bcr1875. Epub 2008 Mar 10.

28.

Pharmacodynamics of streptavidin-coated cyanoacrylate microbubbles designed for molecular ultrasound imaging.

Palmowski M, Morgenstern B, Hauff P, Reinhardt M, Huppert J, Maurer M, Woenne EC, Doerk S, Ladewig G, Jenne JW, Delorme S, Grenacher L, Hallscheidt P, Kauffmann GW, Semmler W, Kiessling F.

Invest Radiol. 2008 Mar;43(3):162-9. doi: 10.1097/RLI.0b013e31815a251b.

PMID:
18301312
29.

Molecular profiling of angiogenesis with targeted ultrasound imaging: early assessment of antiangiogenic therapy effects.

Palmowski M, Huppert J, Ladewig G, Hauff P, Reinhardt M, Mueller MM, Woenne EC, Jenne JW, Maurer M, Kauffmann GW, Semmler W, Kiessling F.

Mol Cancer Ther. 2008 Jan;7(1):101-9. doi: 10.1158/1535-7163.MCT-07-0409.

30.

Bottlenecked but long-lived: high genetic diversity retained in white-tailed eagles upon recovery from population decline.

Hailer F, Helander B, Folkestad AO, Ganusevich SA, Garstad S, Hauff P, Koren C, Nygård T, Volke V, Vilà C, Ellegren H.

Biol Lett. 2006 Jun 22;2(2):316-9.

31.

The in vitro stability of air-filled polybutylcyanoacrylate microparticles.

Olbrich C, Hauff P, Scholle F, Schmidt W, Bakowsky U, Briel A, Schirner M.

Biomaterials. 2006 Jul;27(19):3549-59. Epub 2006 Mar 14.

PMID:
16537092
32.

In vivo molecular imaging of adhesion molecules in experimental autoimmune encephalomyelitis (EAE).

Linker RA, Reinhardt M, Bendszus M, Ladewig G, Briel A, Schirner M, Mäurer M, Hauff P.

J Autoimmun. 2005 Nov;25(3):199-205. Epub 2005 Oct 24.

PMID:
16249069
33.

Evaluation of gas-filled microparticles and sonoporation as gene delivery system: feasibility study in rodent tumor models.

Hauff P, Seemann S, Reszka R, Schultze-Mosgau M, Reinhardt M, Buzasi T, Plath T, Rosewicz S, Schirner M.

Radiology. 2005 Aug;236(2):572-8.

PMID:
16040915
34.

Comparison of two tricarbocyanine-based dyes for fluorescence optical imaging.

Perlitz C, Licha K, Scholle FD, Ebert B, Bahner M, Hauff P, Moesta KT, Schirner M.

J Fluoresc. 2005 May;15(3):443-54.

PMID:
15986163
35.

[Possible target specific molecular imaging with ultrasound contrast agents].

Mäurer M, Linker R, Reinhardt M, Hauff P.

Radiologe. 2005 Jun;45(6):560-8. Review. German.

PMID:
15912322
36.

Ultrasound derived imaging and quantification of cell adhesion molecules in experimental autoimmune encephalomyelitis (EAE) by Sensitive Particle Acoustic Quantification (SPAQ).

Reinhardt M, Hauff P, Linker RA, Briel A, Gold R, Rieckmann P, Becker G, Toyka KV, Mäurer M, Schirner M.

Neuroimage. 2005 Aug 15;27(2):267-78.

PMID:
15905104
37.

Sensitive particle acoustic quantification (SPAQ): a new ultrasound-based approach for the quantification of ultrasound contrast media in high concentrations.

Reinhardt M, Hauff P, Briel A, Uhlendorf V, Linker RA, Mäurer M, Schirner M.

Invest Radiol. 2005 Jan;40(1):2-7.

PMID:
15597013
38.

Molecular imaging of tumor angiogenesis.

Schirner M, Menrad A, Stephens A, Frenzel T, Hauff P, Licha K.

Ann N Y Acad Sci. 2004 Apr;1014:67-75. Review.

PMID:
15153421
39.

Molecular targeting of lymph nodes with L-selectin ligand-specific US contrast agent: a feasibility study in mice and dogs.

Hauff P, Reinhardt M, Briel A, Debus N, Schirner M.

Radiology. 2004 Jun;231(3):667-73. Epub 2004 Apr 29.

PMID:
15118116
40.

Activated signal transducer and activator of transcription 3 (STAT3) supports the malignant phenotype of human pancreatic cancer.

Scholz A, Heinze S, Detjen KM, Peters M, Welzel M, Hauff P, Schirner M, Wiedenmann B, Rosewicz S.

Gastroenterology. 2003 Sep;125(3):891-905.

PMID:
12949733
41.

Radio-frequency ablation of VX2 rabbit tumors: assessment of completeness of treatment by using contrast-enhanced harmonic power Doppler US.

Boehm T, Malich A, Goldberg SN, Hauff P, Reinhardt M, Reichenbach JR, Müller W, Fleck M, Seifert B, Kaiser WA.

Radiology. 2002 Dec;225(3):815-21.

PMID:
12461266
42.

Pharmaceutical evaluation of gas-filled microparticles as gene delivery system.

Seemann S, Hauff P, Schultze-Mosgau M, Lehmann C, Reszka R.

Pharm Res. 2002 Mar;19(3):250-7.

PMID:
11934230
43.

Radio-frequency tumor ablation: internally cooled electrode versus saline-enhanced technique in an aggressive rabbit tumor model.

Boehm T, Malich A, Goldberg SN, Reichenbach JR, Hilger I, Hauff P, Reinhardt M, Fleck M, Kaiser WA.

Radiology. 2002 Mar;222(3):805-13.

PMID:
11867805
44.

Tumor vascularization in experimental melanomas: correlation between unenhanced and contrast enhanced power Doppler imaging and histological grading.

Schroeder RJ, Hauff P, Bartels T, Vogel K, Jeschke J, Hidajat N, Maeurer J.

Ultrasound Med Biol. 2001 Jun;27(6):761-71.

PMID:
11516536
45.

First experiences in using a new ultrasound mode and ultrasound contrast agent in the diagnosis of blunt renal trauma: a feasibility study in an animal model.

Hochmuth A, Fleck M, Hauff P, Reinhardt M, Kosmehl H, Hilger I, Dinkelborg L, Kaiser WA.

Invest Radiol. 2000 Mar;35(3):205-11.

PMID:
10719831
46.

Wideband harmonic imaging: a novel contrast ultrasound imaging technique.

Bauer A, Hauff P, Lazenby J, von Behren P, Zomack M, Reinhardt M, Schlief R.

Eur Radiol. 1999;9 Suppl 3:S364-7.

PMID:
10602930
47.

Delineation of experimental liver tumors in rabbits by a new ultrasound contrast agent and stimulated acoustic emission.

Hauff P, Fritzsch T, Reinhardt M, Weitschies W, Lüders F, Uhlendorf V, Heldmann D.

Invest Radiol. 1997 Feb;32(2):94-9.

PMID:
9039581
48.

[Contrast medium supported imaging of tumorous vessels by color Doppler and power Doppler mode in animal experiments].

Graubner T, Fritzsch T, Hauff P, Kaiser WA.

Rofo. 1996 Dec;165(6):563-7. German.

PMID:
9026099
49.

Properties of two epithelial cell lines derived from HPV-associated cervical and vulvar lesions.

Kiessling U, Kube D, Janda J, Bergmann S, Johannsmeyer KD, Hauff P, Arnoldt W, Waehlte H.

Eur J Cancer. 1993;29A(12):1746-53.

PMID:
8104442
50.

Investigations of droloxifene and other hormonal manipulations on N-nitrosomethylurea-induced rat mammary tumours. 2. Influence on oestrogen receptor.

Görlich M, Winterfeld G, Hauff P, Arnold W, Fichtner I, Staab HJ.

J Cancer Res Clin Oncol. 1992;119(2):97-100.

PMID:
1429832

Supplemental Content

Support Center